Bromodiphenhydramine Hydrochloride

CHEMBL1200967 Phase 4 Одобрено Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
370.7 g/mol
LogP
Phase
4

The hydrochloride salt of bromodiphenhydramine, an older first-generation antihistamine used for cough and allergy relief. Like other first-generation antihistamines, it causes significant sedation and anticholinergic effects. It is no longer widely available in most markets.

Молекулярная масса

370,7000 g/mol

TPSA

12,50 Ų

Механизм действия

Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Механизм

Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.

2D Структура

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1.Cl

InChI

InChI=1S/C17H20BrNO.ClH/c1-19(2)12-13-20-17(14-6-4-3-5-7-14)15-8-10-16(18)11-9-15;/h3-11,17H,12-13H2,1-2H3;1H

Molecular Formula

C17H21BrClNO

HBD / HBA

1 / 2

Вращаемые Связи

6

Тяжёлые Атомы

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

The hydrochloride salt of bromodiphenhydramine, an older first-generation antihistamine used for cough and allergy relief. Like other first-generation antihistamines, it causes significant sedation and anticholinergic effects. It is no longer widely available in most markets.

Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.

Yes, Bromodiphenhydramine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200967. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 519514. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.